Together with its ligand SDF1 it promotes progression and metastatatic homing of a number of malignant diseases including prostate, non–small-cell lung, pancreatic, breast, gastric and esophageal cancer [36]–[44]. This evidence concerns the gene CXCL12 and esophageal cancer.